Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Sodium salicylate

Sodium salicylate

pharmaceutical raw materials
Sodium salicylate structure

Sodium salicylate 

structure
  • CAS No:

    54-21-7

  • Formula:

    C7H6O3.Na

  • Chemical Name:

    Sodium salicylate

  • Synonyms:

    Benzoic acid,2-hydroxy-,sodium salt (1:1);Sodium salicylate;Salicylic acid,monosodium salt;Benzoic acid,2-hydroxy-,monosodium salt;Aroall;Clin;Enterosalil;Magsalyl;Salicylic acid sodium salt;Sodium salicylate (NaO3C7H5);Monosodium salicylate;Sodium o-hydroxybenzoate;Entrosalyl;Salisod;Glutosalyl;Salsonin;Kerasalicyl;Kerosal;Nadisal;Neo-Salicyl;Sodium 2-hydroxybenzoate;Camporisin;o-Hydroxybenzoic acid monosodium salt;Enterosalicyl;Alysine;Idocyl;Saliject;NaSal 31821-45;18495-69-7;94413-51-1

  • Categories:

    Cosmetic Ingredient  >  Cosmetic Preservative

Description

Sodium Salicylate inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation.


DryPowder; Liquid


Sodium salicylate is an organic molecular entity.|Sodium Salicylate is the sodium salt of salicylic acid. As a nonsteroidal anti-inflammatory drug (NSAID), sodium salicylate irreversibly acetylates cyclooxygenases I and II, thereby inhibiting prostaglandin synthesis and associated inflammation and pain. This agent may also activate mitogen-activated protein kinase (p38MAPK), thereby inducing apoptosis in cancer cells. (NCI04)|A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. (From AMA Drug Evaluations Annual, 1992, p120)

Sodium salicylate Basic Attributes

160.10300

160.01400

290-777-4

WIQ1H85SYP

DTXSID5021708

C834

N - Nervous system

2918211000

Characteristics

60.36000

-1.43 (LogP)

DryPowder; Liquid

0.32 g/cm3 (20℃)

213 °C (decomp)

336.3ºC at 760mmHg

144.5ºC

1.435

H2O: 1000 g/L (20 ºC)

Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed.

LD50 i.p. in rats: 780 mg/kg (Goldenthal)

122.9 Ų [M-H]-

Safety Information

NONH for all modes of transport

1

R22

S26; S36

VO5075000

Xn

Stable. Incompatible with mineral acids, metallic salts, iodine. May be light-sensitive.

P301 + P312 + P330-P305 + P351 + P338

H302-H319

|Warning|H302 (96.98%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P264, P270, P280, P281, P301+P312, P305+P351+P338, P308+P313, P330, P337+P313, P405, and P501|Aggregated GHS information provided by 434 companies from 18 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H302: Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501

Drug Information

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)|Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)

Salicylate, Sodium

Sodium salicylate Use and Manufacturing

Uses

An analgesic and antipyretic.Organic synthetic raw materials, preservatives, reagents for measuring free acids in gastric juice. Antipyretic analgesics and antirheumatic drugs. Antipyretic and analgesic, anti-rheumatic drugs, used for the treatment of active rheumatism, rheumatoid arthritis and other diseases. It is used for microanalysis and determination of uranium dioxide and organic synthesis, and as a preservative. Used for spot analysis of uranium dioxide; used for measuring free acid in gastric juice. Used as raw materials for organic synthesis; preservatives; reagents for measuring free acids in gastric juice; spot analysis of uranium dioxide.


Lubricants and lubricant additives


Animal Feed

Production

500,000 - 1,000,000 lb

Agriculture, forestry, fishing and hunting|Benzoic acid, 2-hydroxy-, sodium salt (1:1): ACTIVE

Cosmetics -> Preservative

Computed Properties

Molecular Weight:160.10
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:1
Exact Mass:160.01363830
Monoisotopic Mass:160.01363830
Topological Polar Surface Area:60.4
Heavy Atom Count:11
Complexity:138
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

By inhibiting cyclooxygenase and reducing the synthesis of prostaglandins, it has anti-inflammatory, anti-rheumatic, antipyretic and analgesic effects. Its anti-inflammatory and anti-rheumatic effects are similar to those of aspirin, but its antipyretic and analgesic effects are weaker. This product has no antiplatelet aggregation effect.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of Sodium salicylate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.